How many employees work at GC Therapeutics?
GC Therapeutics, Inc. has approximately 36 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. GC Therapeutics’s total headcount has grown 85.0% from 19 employees in 2023 to 36 in 2026.
Is GC Therapeutics hiring right now?
Yes, GC Therapeutics is actively hiring. GC Therapeutics had 2 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About GC Therapeutics’s Workforce
GC Therapeutics, Inc. is a Biotech and Healthcare Services company that employs 36 people worldwide as of March 2026. It is the 6th-largest by headcount among its peers. Founded in 2019, the company is headquartered in Cambridge, Massachusetts.
GC Therapeutics's workforce has grown 85.0% from 2023 to 2026, though it is down 9.8% year over year in 2026. Its workforce is concentrated most in North America (100.0%).
GC Therapeutics's functional groups are Engineering (56.1%), Finance and Operations (29.2%), and Sales and Marketing (14.7%), with Engineering growing fastest (up 13.6%). The average salary is $143,882, highest in North America at a median of $142,000, up 3.8% year over year in 2026.
GC Therapeutics's hiring activity held steady in 2026. Overall employee sentiment is negative but improving.
Sourced from Revelio Labs workforce data.
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2019
- Industry
- Biotech and Healthcare Services
- Employees
- 36
- YoY
- -9.8% (-5)
As of March 2026
GC Therapeutics workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for GC Therapeutics. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsGC Therapeutics Annual Employee Count (2023-2026)
- GC Therapeutics had 36 employees in 2026, a 9.8% decline (-5) from 2025.
- GC Therapeutics had 38 employees in 2025, a 9.5% decline (-1) from 2024.
- GC Therapeutics had 39 employees in 2024, a 9.6% increase (+6) from 2023.
- GC Therapeutics had 33 employees in 2023, a 19.6% increase (+15) from 2022.
GC Therapeutics's total workforce has grown from 19 employees in 2023 to 36 in 2026.
GC Therapeutics, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 36 | -5 | -9.8% |
| 2025 | Q4 | 38 | -1 | -9.5% |
| 2025 | Q3 | 39 | +2 | -0.5% |
| 2025 | Q2 | 42 | +7 | +0.8% |
| 2025 | Q1 | 41 | +8 | +6.4% |
| 2024 | Q4 | 39 | +6 | +9.6% |
| 2024 | Q3 | 37 | +13 | +7.4% |
| 2024 | Q2 | 35 | +16 | +27.6% |
| 2024 | Q1 | 33 | +17 | +20.8% |
| 2023 | Q4 | 33 | +15 | +19.6% |
| 2023 | Q3 | 24 | +6 | +13.5% |
| 2023 | Q2 | 19 | -1 | -0.7% |
See GC Therapeutics's complete headcount history, including quarterly breakdowns.
Get the DataGC Therapeutics Employee Count by Region (2026)
North America accounts for the largest share of GC Therapeutics's global workforce with approximately 100% of total employees.
GC Therapeutics employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 34 | 100.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataGC Therapeutics Employee Count by Department (2026)
GC Therapeutics's employee groups are Engineering (56.1%), Finance and Operations (29.2%), and Sales and Marketing (14.7%).
GC Therapeutics employees by department
| Department | Employees | % of Total |
|---|---|---|
| Engineering | 20 | 56.1% |
| Finance and Operations | 10 | 29.2% |
| Sales and Marketing | 5 | 14.7% |
Compare GC Therapeutics's department mix to industry peers.
See Full DataGC Therapeutics Employee Salary by Region (2026)
GC Therapeutics's average employee salary is $143,882 globally. Employees in North America receive the highest compensation.
GC Therapeutics median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $142,000 |
Unlock salary by role, level, and city — and compare to GC Therapeutics's industry peers.
Unlock Salary DataGC Therapeutics Job Openings and Hiring Trends (2023-2026)
- GC Therapeutics had 2 active job postings in 2026, a 0% no change from 2025.
- GC Therapeutics had 2 active job postings in 2025, a 66.7% increase (+1) from 2024.
- GC Therapeutics had 1 active job postings in 2024, a 0% no change from 2023.
- GC Therapeutics had 1 active job postings in 2023, a 200.0% increase from 2022.
- Hiring velocity in 2026: 1 new roles/month, up from 1 in 2025 and 2 in 2024.
GC Therapeutics's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataGC Therapeutics Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across GC Therapeutics's workforce based on public professional data. Overall sentiment is negative and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About GC Therapeutics
- How fast is GC Therapeutics growing?
- In 2026, GC Therapeutics's headcount shrank 9.8% to 36 employees, down from 41 in 2025.
- See the full headcount history
- Where are GC Therapeutics employees located?
- Most GC Therapeutics employees are based in North America (100.0% of headcount).
- Explore where the workforce is based
- What is the average salary at GC Therapeutics?
- The average employee salary at GC Therapeutics is approximately $143.9k per year.
- Analyze the salary distribution
- How many new job postings does GC Therapeutics open per year?
- In Q1 2026, GC Therapeutics opened 2 new job postings. In 2025, GC Therapeutics opened 14 new job postings — about 1 per month.
- Track hiring trends by role
- When was GC Therapeutics founded and where is it headquartered?
- GC Therapeutics was founded in 2019 and is headquartered in Cambridge, Massachusetts.
- Compare GC Therapeutics to industry peers
Speak with a workforce expert about GC Therapeutics.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.